2010 is drawing to a close, and looking back on the year, great achievements have been made in the field of health care, and we see hope for the harmonious and sustainable development of medical care. Ai Ai Medical has summarized these events and selected the top ten medical news events of 2010. If you have different opinions you can propose, let’s witness the history of 2010 together. Superbug outbreak “Superbug” refers to the emergence of multi-drug resistant bacteria that can cause thick sores and blisters in humans, and even gradually cause muscle necrosis. The infection causes terrible inflammation, high fever, seizures, coma and eventually death. The scary thing about this germ is its resistance to common antiseptic drugs – antibiotics. Control of antimicrobial resistance is the theme of World Health Day 2011, and the World Health Organization recently renewed its call for greater global efforts to control antimicrobial resistance by developing and using clinical diagnostics and adopting increasingly improved global information technology to track and control the spread of the resistance problem and avoid the continued emergence of “superbugs “The first First Chinese National Formulary Released On February 7, the Ministry of Health released China’s first “Chinese National Formulary (Chemical and Biological Products Volume, 2010 Edition)” to guide the rational use of clinical drugs and regulate hospital drug use. The prescription set includes drug treatment plans and related drug information for 20 clinical systems and 199 common diseases, covering a total of 1,336 types of Western drugs and other commonly used drugs in the National Basic Drug List and the National Basic Medical Insurance List. The preparation and release of the prescription set lays the foundation for standardizing medical practice, improving the level of clinical drug application and implementing clinical pathway management, and is of great significance in promoting doctor-patient communication and establishing a harmonious doctor-patient relationship. The results of a cross-sectional epidemiological survey completed by Professor Jia Weiping of the Sixth People’s Hospital of Shanghai Jiaotong University showed that glycosylated hemoglobin ≥6.3% was equivalent to or even better than fasting glucose ≥7.0 mmol/L for the diagnosis of diabetes, and the study was published in the British Medical Journal. The study provides a diagnostic cutpoint for HbA1c (HbA1c ≥6.3%) from a Chinese population study, providing a new means of improving the diagnostic efficacy of diabetes. However, in the forthcoming 2010 edition of the Chinese guidelines for the prevention and treatment of type 2 diabetes, the current diagnostic criteria for diabetes (WHO 1999 edition) are followed, and glycosylated hemoglobin is not included in the diagnostic criteria for the time being. Revised CPR guidelines Since the introduction of CPR in 1960, first responders have saved countless lives over the past 50 years in the same way: mouth-to-mouth respiration combined with chest compressions to revive an unconscious person. However, the American Heart Association decided to update the decades-old technique after new data showed that chest compressions alone were as effective as traditional CPR in resuscitating patients in cardiac arrest. The new rules for CPR focus more on chest compressions, which can sometimes be supplemented with mouth-to-mouth respiration. The new first aid guidelines recommend that all rescuers, including professionally trained medical emergency personnel, reverse the current order of CPR and perform 30 minutes of vigorous chest compressions, followed by mouth-to-mouth respiration. According to American Heart Association experts, for those whose hearts may be in danger, the first consideration is to get the heart beating again, and starting first aid with chest compressions may minimize the damage caused by a stopped heart. Blood tests can diagnose heart attacks Heart attacks begin with blocked blood vessels, so blood tests can be a more ideal way to predict heart problems. Currently, the most reliable way to check cardiovascular conditions is by angiography. This is an invasive procedure that requires a thin tube to be inserted into the blood vessels of the thigh arteries. Now that researchers have identified 23 genes that specify the genetic code for blood white matter synthesis, the accuracy of using this approach to check for blockages in blood vessels associated with heart disease is as high as 83 percent. If doctors combine this blood test with existing means of diagnosing heart attack risk – including chest pain symptoms and family history of the disease – the accuracy of determining whether a patient is in a high- or low-risk group would increase by 16 percent over using traditional means alone. It is unrealistic to expect that a blood test by itself can predict a heart attack, at least for now, but for those at high risk, it can serve as an early warning sign. Perhaps by changing their diet and lifestyle habits, these patients can prevent heart attacks. American man successfully cured of AIDS As a disease that destroys the body’s immune system, AIDS has been a problem for the world’s medical community, and there is no effective way to cure it. However, according to the Associated Press on December 15, German researchers recently published a report in the new issue of the American monthly “Blood” that they had successfully cured a leukemia patient of AIDS through bone marrow transplant therapy. When the HIV virus could no longer be found in Brown’s body, Reuters wrote in its report that this was “an absolutely deafening discovery in a field where people are afraid to even mention the word ‘cure’ out loud. Father of IVF wins Nobel Prize The 2010 Nobel Prize in Physiology or Medicine was awarded to the British physiologist Robert Edwards, known as the “father of IVF. Edwards. His pioneering technique of in vitro fertilization has enabled more than 4 million births. Edwards’ achievement made it possible to treat infertility. Medical statistics show that one in ten couples in the world has a fertility problem, and it has helped bring happiness to infertile couples around the world, an achievement that represents a milestone in modern medical technology. The Thousand Genomes Project The Thousand Genomes Project, a large international research collaboration initiated by Chinese, American and British research institutions, released the most detailed map of human genetic polymorphisms to date in the form of a cover article in the British journal Nature on October 28, and also reported in the American journal Science on the gains in genetic research. The results mark an epoch-making new stage in human genetic research. The researchers at Brown University have created an artificial ovary that can fully assume the functions of a human ovary for the first time, and have used it to grow mature human eggs, according to a Sept. 15 report in The Physicist. The research was published in the latest issue of the journal Assisted Reproductive Technology and Genetics. The most immediate impact of a successful artificial ovary is that it could help technicians in the field of artificial insemination to improve their success rates. In addition, artificial ovaries may be able to help women with ovarian disease (such patients cannot produce mature eggs) to have their own babies using artificial insemination techniques. Pregnant women with minimal blood can detect fetal genetic disorders Researchers have discovered a new way to more safely detect many genetic disorders earlier in pregnancy, by collecting a minimal blood sample from a pregnant woman to examine the fetal genome. The study was published online Dec. 8 in the journal Science Translational Medicine. Prenatal testing for genetic disorders has traditionally used invasive means (such as amniocentesis or chorionic villus sampling) to obtain one sample of fetal tissue, which is necessarily risky. Now, and colleagues have demonstrated that pregnant women and physicians may be able to avoid this risk to the fetus by using a sample of the mother’s blood to examine the fetal genome.